Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1988 Feb;85(3):650–653. doi: 10.1073/pnas.85.3.650

Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells.

K J Scanlon 1, M Kashani-Sabet 1
PMCID: PMC279612  PMID: 3422447

Abstract

Activity of the thymidylate synthase cycle was compared in the human ovarian carcinoma cell line A2780 and a subline that is resistant to cisplatin by a factor of 3. Resistant cells exhibited a 3-fold increase in mRNA for both dihydrofolate reductase (5,6,7,8-tetrahydrofolate:NADP+-oxidoreductase, EC 1.5.1.3) and thymidylate synthase (5,10-methylenetetrahydrofolate:dUMP C-methyltransferase, EC 2.1.1.45) when compared with the parent line. Resistance to cisplatin also resulted in a 2.5-fold increase in enzyme activity for dihydrofolate reductase and thymidylate synthase; however, this increase did not result from amplification of the genes for these two enzymes. These data suggest that the initial step of cisplatin resistance in A2780 cells is a consequence of enhanced expression of the thymidylate synthase cycle.

Full text

PDF
652

Images in this article

652Image
on p.652
652Image
on p.652
652Image
on p.652
652Image
on p.652
652Image
on p.652
653Image
on p.653
653Image
on p.653
653Image
on p.653

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrews P. A., Murphy M. P., Howell S. B. Differential sensitization of human ovarian carcinoma and mouse L1210 cells to cisplatin and melphalan by glutathione depletion. Mol Pharmacol. 1986 Dec;30(6):643–650. [PubMed] [Google Scholar]
  2. Ayusawa D., Shimizu K., Koyama H., Kaneda S., Takeishi K., Seno T. Cell-cycle-directed regulation of thymidylate synthase messenger RNA in human diploid fibroblasts stimulated to proliferate. J Mol Biol. 1986 Aug 20;190(4):559–567. doi: 10.1016/0022-2836(86)90241-x. [DOI] [PubMed] [Google Scholar]
  3. Gasser C. S., Schimke R. T. Cell cycle regulation of transfected murine dihydrofolate reductase genes. J Biol Chem. 1986 May 25;261(15):6938–6946. [PubMed] [Google Scholar]
  4. Gross R. B., Scanlon K. J. Amino acid membrane transport properties of L1210 cells resistant to cisplatin. Chemioterapia. 1986 Feb;5(1):37–43. [PubMed] [Google Scholar]
  5. Hayman R., McGready R., Van der Weyden M. B. A rapid radiometric assay for dihydrofolate reductase. Anal Biochem. 1978 Jul 1;87(2):460–465. doi: 10.1016/0003-2697(78)90696-6. [DOI] [PubMed] [Google Scholar]
  6. Kamen B. A., Takach P. L., Vatev R., Caston J. D. A rapid, radiochemical-ligand binding assay for methotrexate. Anal Biochem. 1976 Jan;70(1):54–63. doi: 10.1016/s0003-2697(76)80047-4. [DOI] [PubMed] [Google Scholar]
  7. Krebs H. A., Hems R., Tyler B. The regulation of folate and methionine metabolism. Biochem J. 1976 Aug 15;158(2):341–353. doi: 10.1042/bj1580341. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Morandi C., Masters J. N., Mottes M., Attardi G. Multiple forms of human dihydrofolate reductase messenger RNA. Cloning and expression in Escherichia coli of their DNA coding sequence. J Mol Biol. 1982 Apr 15;156(3):583–607. doi: 10.1016/0022-2836(82)90268-6. [DOI] [PubMed] [Google Scholar]
  9. Ozols R. F., Young R. C. Chemotherapy of ovarian cancer. Semin Oncol. 1984 Sep;11(3):251–263. [PubMed] [Google Scholar]
  10. Rode W., Scanlon K. J., Moroson B. A., Bertino J. R. Regulation of thymidylate synthetase in mouse leukemia cells (L1210). J Biol Chem. 1980 Feb 25;255(4):1305–1311. [PubMed] [Google Scholar]
  11. Rosenberg B. Fundamental studies with cisplatin. Cancer. 1985 May 15;55(10):2303–23l6. doi: 10.1002/1097-0142(19850515)55:10<2303::aid-cncr2820551002>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  12. Scanlon K. J., Berkowitz K., Pallai M. E., Waxman S. Inhibition of methionine transport by methotrexate in mitogen-stimulated human lymphocytes. Cancer Treat Rep. 1983 Jul-Aug;67(7-8):631–639. [PubMed] [Google Scholar]
  13. Scanlon K. J., Cashmore A. R., Kashani-Sabet M., Pallai M., Dreyer R. N., Moroson B. A., Saketos M. Inhibition of methionine uptake by methotrexate in mouse leukemia L1210 cells. Cancer Chemother Pharmacol. 1987;19(1):21–24. doi: 10.1007/BF00296249. [DOI] [PubMed] [Google Scholar]
  14. Scanlon K. J., Cashmore A. R., Kashani-Sabet M., Pallai M., Dreyer R. N., Moroson B. A., Saketos M. Inhibition of methionine uptake by methotrexate in mouse leukemia L1210 cells. Cancer Chemother Pharmacol. 1987;19(1):21–24. doi: 10.1007/BF00296249. [DOI] [PubMed] [Google Scholar]
  15. Scanlon K. J., Newman E. M., Lu Y., Priest D. G. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci U S A. 1986 Dec;83(23):8923–8925. doi: 10.1073/pnas.83.23.8923. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Scanlon K. J., Safirstein R. L., Thies H., Gross R. B., Waxman S., Guttenplan J. B. Inhibition of amino acid transport by cis-diamminedichloroplatinum(II) derivatives in L1210 murine leukemia cells. Cancer Res. 1983 Sep;43(9):4211–4215. [PubMed] [Google Scholar]
  17. Schabel F. M., Jr, Skipper H. E., Trader M. W., Laster W. R., Jr, Griswold D. P., Jr, Corbett T. H. Establishment of cross-resistance profiles for new agents. Cancer Treat Rep. 1983 Oct;67(10):905–922. [PubMed] [Google Scholar]
  18. Shionoya S., Lu Y., Scanlon K. J. Properties of amino acid transport systems in K562 cells sensitive and resistant to cis-diamminedichloroplatinum(II). Cancer Res. 1986 Jul;46(7):3445–3448. [PubMed] [Google Scholar]
  19. Singer-Sam J., Simmer R. L., Keith D. H., Shively L., Teplitz M., Itakura K., Gartler S. M., Riggs A. D. Isolation of a cDNA clone for human X-linked 3-phosphoglycerate kinase by use of a mixture of synthetic oligodeoxyribonucleotides as a detection probe. Proc Natl Acad Sci U S A. 1983 Feb;80(3):802–806. doi: 10.1073/pnas.80.3.802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Teicher B. A., Cucchi C. A., Lee J. B., Flatow J. L., Rosowsky A., Frei E., 3rd Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines. Cancer Res. 1986 Sep;46(9):4379–4383. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES